|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:12 AM EST, 02/07/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.25% to 1,383.65 on the S&P Europe Select ADR Index. Despite the loss the index is up 3.2% for the week.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and furniture maker Natuzzi (NTZ), which advanced 9.7% and 1% respectively. They were followed by internet browser company Opera (OPRA) and telecommunications operator Telefonica (TEF), which rose 4% and 1.8% respectively.
The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and Grifols (GRFS), which dropped 6.4% and 1.7% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Cellectis (CLLS), which fell 3.6% 2.5% respectively.
From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which increased 2.1% and 1.7% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and oil and gas company BP (BP), which were up 0.8% and 0.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and biotech firm Autolus Therapeutics (AUTL), which lost 12.4% and 4.5% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were down 6.1% and 3.7% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.